APA (7th ed.) Citation

P, M., MP, Y., AD, A., A, P., C, T., & SE, P. (2024). Transient osteoporosis of the hip following discontinuation of denosumab and switch to alendronate treatment. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 35(4), 741. https://doi.org/10.1007/s00198-023-07000-5

Chicago Style (17th ed.) Citation

P, Makras, Yavropoulou MP, Anastasilakis AD, Papatheodorou A, Tekedis C, and Papapoulos SE. "Transient Osteoporosis of the Hip Following Discontinuation of Denosumab and Switch to Alendronate Treatment." Osteoporosis International : A Journal Established as Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 35, no. 4 (2024): 741. https://doi.org/10.1007/s00198-023-07000-5.

MLA (9th ed.) Citation

P, Makras, et al. "Transient Osteoporosis of the Hip Following Discontinuation of Denosumab and Switch to Alendronate Treatment." Osteoporosis International : A Journal Established as Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, vol. 35, no. 4, 2024, p. 741, https://doi.org/10.1007/s00198-023-07000-5.